The TTG DGP Combined Screen Panel is a blood test that measures antibodies against tissue transglutaminase (tTG) and deamidated gliadin peptide (DGP), both of which are markers for celiac disease and gluten sensitivity. This panel is used to screen individuals with symptoms like chronic diarrhea, abdominal pain, bloating, or unexplained anemia. Detecting these antibodies helps doctors confirm gluten-related disorders, guide dietary management, and prevent long-term complications associated with untreated celiac disease.
It helps confirm gluten-related disorders, guiding dietary management and preventing complications like malnutrition, osteoporosis, and intestinal damage caused by untreated celiac disease.
Individuals with chronic diarrhea, bloating, abdominal pain, unexplained anemia, or suspected gluten intolerance are recommended for this test.
Persistent digestive issues, fatigue, weight loss, or unexplained nutrient deficiencies often lead doctors to order this test.
A positive result suggests celiac disease or gluten sensitivity. Health care professionals may recommend a gluten-free diet and further evaluation.
A negative result means antibodies were not detected, reducing the likelihood of celiac disease, though other causes of symptoms may still need investigation.
Yes, immunosuppressive drugs may influence antibody levels. Inform your doctor about all medications before testing.
Without testing, untreated celiac disease can lead to malnutrition, growth problems, and long-term complications.
...
Didn't recieved OTP Yet? Resend OTP